ICYMI: New Drugs Push Pharmaceutical Profits Up

According to an article via SFgate.com, “Revenue from important new medicines for various cancers, hepatitis C and more helped top U.S. drugmakers weather unfavorable currency exchange rates and other challenges. Pfizer Inc., Merck & Co. and Bristol-Myers...